BALB/c nude mice were injected intrahepatically with hepatitis B virus (HBV) DNA 
BALB/c nude mice were injected intrahepatically with hepatitis B virus (HBV) DNA prepared from recombinant plasmids. Hepatitis B surface antigen appeared in the circulation in 19 of 23 mice (82%) 3 to 20 weeks postinjection and persisted for more than 6 months in most animals. Hepatitis B e antigen appeared transiently in the circulation in 12 of the 23 mice (52%) within a few weeks after the appearance of hepatitis B surface antigen. Antibodies to the core, X, and/or polymerase gene products of HBV have also been observed in 14 (61%) of the mice. Histopathological examination of the livers at 7 months postinjection demonstrated that nearly half had characteristics consistent with chronic hepatitis. HBV DNA appeared to be integrated into host liver DNA. No evidence of viral replication was observed in sera or livers from these mice at 7 months postinjection. These results demonstrate that an HBV chronic carrierlike state can be established in mice and that such a model could be used to study host and virus factors important in the establishment and maintenance of HBV-associated chronic liver disease.
Hepatitis B virus (HBV) infection is a worldwide public health problem with more than 200 million estimated carriers (20) . Until recently, an understanding of the biology of HBV infection has been hampered by the lack of a reproducible and long-term tissue culture system for viral propagation and by the very narrow host range of infection. The chronic carrier state has been successfully established by experimental infection of chimpanzees (2) with HBV or HBV DNA (22, 23) , but the infection is self-limiting and chimpanzees are both expensive and endangered, thereby limiting the number and types of studies which could be done. The discovery and characterization of HBV-like viruses in other animals, such as ground squirrel hepatitis virus (12) , woodchuck hepatitis virus (19) , duck hepatitis B virus (14) , and tree squirrel hepatitis B virus (8) has provided much information about their biology, including some information concerning the carrier state. The expense and difficulty in handling these animals, however, has limited their use. The recent construction of several transgenic mice expressing hepatitis B surface antigen (HBsAg) in serum and in some tissues (1, 3) will permit the detailed study of HBsAg biosynthesis in vivo. Although transgenic mice demonstrate evidence of chronic hepatitis (2a), the pathology described is due to overproduction of surface antigen and not likely to be immune mediated, as in natural infections. Therefore, transgenic mice will be of litnited usefulness in studying the mechanism of liver disease associated with the chronic carrier state. In this study, inbred laboratory mice injected intrahepatically (i.h.) with HBV DNA develop circulating HBsAg, hepatitis B e antigen (HBeAg), and chronic hepatitis, providing a new system for studying the relationships between HBV gene expression, host immune response, and chronic liver disease.
MATERIALS AND METHODS
Mice. Female BALB/c nude mice (BALB/c nulnu), 2 to 3 months of age, were obtained from matings of BALB/c (+Inu) heterozygote parents in the Laboratory Animal Facility of the Fox Chase Cancer Center. This nude mouse colony has been periodically screened for the presence of common mouse pathogens and evidence of disease in different organ systems. Mice used in these studies were derived from a colony free of any gross or microscopic liver abnormalities, including hepatitis. Mouse livers were also screened for the presence of mouse hepatitis virus (MHV), using a rabbit antiserum specific for common MHV nucleocapsid associated antigens, followed by a biotinylated goat anti-rabbit immunoglobulin, soluble avidin-biotin-peroxidase complex (Vector Laboratories, Burlingame, Calif.), and diaminobenzidine as substrate.
i.h. injections. For i.h. injection of DNA, mice were anesthetized intraperitoneally with 0.3 ml of 10% pentobarbital sodium (Nembutal; Abbott Laboratories, North Chicago, Ill.). In each animal, the midline of the upper abdomen was opened to reveal the liver and a total of 100 ,ug of DNA was injected into several sites. The DNA species used for injection are as follows. (i) A total of 15 mice were injected with HBV DNA (adw clone [18] ) derived from a full-length, single-copy, EcoRI insert of viral DNA in pBR322 (Fig. 1) . Recombinant plasmids were grown in Escherichia coli and isolated exactly as previously described (16) , cut with EcoRI to release the full-length HBV DNA insert, and finally ligated with T4 DNA ligase (New England BioLabs, Inc., Beverly, Mass.) under conditions favoring intramolecular ligation (11) . The appearance of covalently closed circular monomers of HBV DNA (CCC HBV DNA) was monitored by agarose gel electrophoresis. For injection, the mixture containing religated monomers of HBV DNA was used without attempts at separation from pBR322 sequences. (ii) Another eight mice were injected with a head-to-tail EcoRI tandem HBV DNA dimer inserted into pBR322 sequences (pTKHH2, a gift from Hans Will; Fig. 1 ). This clone had been previously shown to be infectious in chimpanzees (22) to 131, whereas the polymerase peptides used spanned residues 29 to 38, 781 to 795, and 822 to 838. In all assays, the OD492 value of the first serum collected from a given mouse (before HBV DNA injection) was subtracted from the successive serial sera in the same animal. The net OD492 values were scored as positive if they repeatedly yielded values greater than two standard deviations above the mean of the negative controls, as defined in the HBsAg assay described above.
Evaluation of liver tissue for HBV DNA and pathology. At 7 months postinjection, mice were sacrificed and the livers were removed for further analysis. Tissue sections were prepared from several regions of each liver, stained with hematoxylin and eosin, and evaluated for pathology by light microscopy. Most of each liver was frozen in dry ice and stored at -70°C. Total cellular DNA was extracted from approximately 0.3 g of tissue from each liver (13) and used for Southern analysis. Electrophoresis was carried out by using gels of 1% agarose loaded with 5 ,ug of DNA per lane as previously described (14) . For each liver, DNA samples were examined before and after digestion with HindIII or with EcoRI (Boehringer Mannheim Biochemicals, Indianapolis, Ind.). After electrophoresis, the digestion products and size markers (HindIl fragments of phage A DNA; Bethesda Research Laboratories, Inc., Gaithersburg, Md.) were visualized after staining with ethidium bromide, partially depurinated with sodium acetate, and then blotted to nitrocellulose (BA85; Schleicher & Schuell). Hybridizations were carried out at stringent conditions (10), using full-length HBV DNA cut out from pBR322 by EcoRI digestion, isolated from pBR322 by agarose gel electrophoresis, electroeluted, and radiolabeled by primer extension (4). Separate gel lanes were hybridized with pBR322 (Boehringer Mannheim) to test for the presence of vector sequences in the liver DNAs from HBV DNA-injected mice.
RESULTS
Detection of HBsAg and HBeAg in nude mice. The experimental design outlined in Fig. 1 was chosen to test for the possible appearance of HBV, HBsAg, or both in HBV DNA-injected mice from serial sera collected over a period of several months. All sera were negative for the endogenous DNA polymerase activity associated with HBV, consistent with the absence of complete virus (data not shown). However, testing of serial sera by solid-phase immunoassays demonstrated HBsAg appearing in the sera of about 80% of the mice from 3 to 13 weeks after i.h. injection of HBV DNA (Table 1 ). In addition, nearly 60% of the HBsAg-positive animals also became transiently seropositive for HBeAg within 2 months after the appearance of HBsAg (Table 1) . From the time of onset, HBeAg remained detectable in different mice from 2 to 10 weeks in duration. Mice injected with either the HBV DNA-recircularized and -ligated monomer (CCC HBV DNA) or the HBV DNA tandem dimer in a recombinant plasmid (pTKHH2) produced both HBsAg and HBeAg. When the levels of surface antigen particles for each mouse were quantitated by Western blotting by using a 125I-anti-HBs, the HBsAg concentration varied for different mice (Table 1 ) but remained relatively constant for a given mouse (data not shown). Mice which became HBsAg positive within a few weeks of injection remained positive for the remaining 6 months of the experiment, demonstrating that a chronic HBsAg carrierlike state could be established in mice by i.h. injection of HBV DNA.
Partial characterization of HBsAg particles. Characterization of the HBsAg-reactive species was carried out by using The density of the surface antigen particles in the sera of mice was determined by density equilibrium centrifugation in CsCI (Fig. 3 ). Fractions were analyzed for the presence of the major HBsAg components at 25,000 and 29,000 daltons by SDS-PAGE and Western blotting. Positive fractions had densities near 1.2 g/ml in CsCl, which is also the density of HBsAg particles derived from human sera.
Six of these sera were pelleted overnight by centrifugation and then suspended for examination by electron microscopy (Fig. 4) . Small, spherical particles approximately 20 nm in diameter were observed in each of the sera (panel A). When anti-HBs from an HBV-infected human carrier was added, these particles aggregated in a time-dependent manner, consistent with the presence of HBsAg determinants (panel B). In the absence of anti-HBs or in the presence of normal human serum, the particles remained unaggregated. Particles were not observed in sera from mice either before DNA injection or after injection with control DNA (panel C).
Presence of antibodies to HBV gene products in nude mouse sera. Serial sera from nude mice were assayed for anti-HBc, anti-HBx, and anti-pol in solid-phase assays (Table 1) . Among the 23 nude mice injected with HBV DNA, 9 (39%) had evidence of anti-HBc, 9 (39%) had evidence of antiHBx, and 7 (30%) had evidence of anti-pol in one or more serial sera after the appearance of HBsAg. Three animals had all of these markers, another four had both anti-HBx and anti-pol, and four more had anti-HBc alone. In addition, 2 animals had both anti-HBc and anti-HBx and the remaining 10 mice were negative for each of these antibody markers.
The results are consistent with the conclusion that the core, X, and polymerase gene products may be made, at least transiently, in these hosts and give rise to antibody responses which are also observed in HBV-infected patients.
State of HBV DNA in nude mouse livers. Mice injected with HBV or control DNA were kept for 7 months and then sacrificed to examine the livers in more detail. The state of HBV DNA in these livers was determined by extracting whole-cell DNA and performing Southern blot hybridization with an HBV DNA probe (Fig. 5) . For panel A, whole-cell DNA extracts from four HBV DNA-injected mice were analyzed before digestion with restriction endonucleases. The hybridization signals were confined to the high-molecular-weight region of the gel, consistent with integration of HBV DNA into the host genome. For panel B, the same experiment was repeated, using whole-cell DNA from two animals injected with control DNA. The absence of signal demonstrates that under the conditions of hybridization, only HBV DNA sequences, and not host sequences, were detected. pBR322 sequences, however, were found associated with high-molecular-weight DNA in some of the HBV DNA-injected animals as well as pBR322-injected control animals (data not shown). For panel C, the liver DNAs from the four animals tested as shown in panel A were digested with HindIII before gel electrophoresis. Each of the animals demonstrated a smear of hybridizable DNA, consistent with random integration of HBV into the host genome. For panel D, the DNAs from the four animals tested as shown in panel A were digested with EcoRI before gel electrophoresis. Each animal demonstrated a smear of hybridizable DNA and a band approximately 3.0 to 3.2 kilobases. The appearance of a 3-kilobase band after EcoRI digestion is consistent with it being full-length HBV DNA, perhaps tandemly integrated into the host genome. The absence of replicating forms of HBV DNA in these experiments shows that HBV was not actively replicating in these livers at 7 months after injection of HBV DNA.
Liver pathology in HBV DNA-injected nude mice. Slices of tissue from different regions of the livers were fixed, hematoxylin-and eosin-stained, and examined for evidence of pathology. Several examples of these results are presented in Fig. 6 , and all of the results are summarized in Table 1 . In the HBV DNA-injected group, nearly half of the mice had one or more characteristics of hepatitis. Among the animals acquiring hepatitis, all demonstrated periportal inflammation involving many portal tracts in different parts of each liver (Fig. 6, panel A) . These lesions were consistent with the diagnosis of chronic persistent hepatitis in 6 of 21 animals (29%) injected with viral DNA. In addition to periportal inflammation, another four animals (19%) had evidence of mild intralobular hepatitis, bridging inflammation, and fibrosis among neighboring portal tracts (Fig. 6 , panels B and C, respectively); this was consistent with the diagnosis of chronic active hepatitis ( HBeAg of variable duration is also characteristic of many patients with chronic HBV infection. The nude mice also maintain HBV DNA in the absence of viral replication. Long-term HBV-infected human carriers often have similar characteristics. In mice, the maintenance mechanism may be integration of viral DNA into host genomic DNA sequences, the presence of concatenated circular viral genomes, or both. In either host, the HBV DNA likely serves as the template for the sustained production of HBsAg. The nude mice also develop lesions in the liver consistent with the presence of chronic hepatitis, as seen in long-term HBV infected patients. Since HBV is not directly cytopathic, it is likely that the liver pathology observed in HBV DNAinjected mice, as in naturally infected patients, is immune mediated. If this is true, then partial or total reconstitution of the immune system in nude mice should significantly alter the frequency of chronic liver disease in these animals and permit identification of immune elements which contribute to the establishment or maintenance of chronic hepatitis.
The presence of HBeAg in the sera of several HBsAgpositive mice is consistent with a peak of virus replication, as it is in many chronically infected patients. Antibodies to the core, X, and polymerase gene products of HBV have also been detected in the sera of these mice. Together, these results are consistent with the expression of all of the known HBV gene products and with virus replication. The absence of HBV-associated DNA polymerase activity from HBeAgpositive sera may indicate low levels or lack of virus in the blood. Sera from transgenic mice carrying a plasmid containing a tandem head-to-tail dimer of HBV DNA were also negative for DNA polymerase activity, although low 
